ORCL · NYSE
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $67.36B | $57.40B | $52.96B | $49.95B | $42.44B | $40.48B | $39.07B | $39.51B |
| Research & Development | $10.27B | $9.86B | $8.91B | $8.62B | $7.22B | $6.53B | $6.07B | $6.03B |
| Selling, General & Administrative | $1.62B | $1.60B | $1.55B | $1.58B | $1.32B | $1.25B | $1.18B | $1.26B |
| Operating Expenses | $46.75B | $39.72B | $37.61B | $36.86B | $31.51B | $25.27B | $25.17B | $25.97B |
| Operating Income | $20.61B | $17.68B | $15.35B | $13.09B | $10.93B | $15.21B | $13.90B | $13.54B |
| Interest Expense | $4.60B | $3.58B | $3.51B | $3.50B | $2.75B | $2.50B | $2.00B | $2.08B |
| Other Income / (Expense) | $309.00M | $91.00M | $168.00M | -$6.00M | -$86.00M | $211.00M | -$16.00M | -$14.00M |
| Provision for Income Taxes | $2.47B | $1.72B | $1.27B | $623.00M | $932.00M | -$747.00M | $1.93B | $1.19B |
| Net Income | $17.09B | $12.44B | $10.47B | $8.50B | $6.72B | $13.75B | $10.13B | $11.08B |
| Basic EPS | $5.94 | $4.46 | $3.82 | $3.15 | $2.49 | $4.67 | $3.16 | $3.05 |
| Diluted EPS | $5.83 | $4.34 | $3.71 | $3.07 | $2.41 | $4.55 | $3.08 | $2.97 |
| Basic Shares Outstanding | 2.86B | 2.79B | 2.74B | 2.70B | 2.70B | 2.94B | 3.21B | 3.63B |
| Diluted Shares Outstanding | 2.91B | 2.87B | 2.82B | 2.77B | 2.79B | 3.02B | 3.29B | 3.73B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| May 2027 | $6.47 | $6.28 | $6.67 | 17 | ↑0 ↓0 |
| May 2028 | $8.78 | $6.39 | $10.08 | 13 | ↑0 ↓0 |
| May 2029 | $14.20 | $14.06 | $14.34 | 2 | ↑0 ↓0 |